GTSE1 and pancreatic adenocarcinoma: However, no significant differences in GTSE1 expression were detected in cases of pancreatic adenocarcinoma (PAAD) and pheochromocytoma and paraganglioma (PCPG) when comparing cancer tissues to control tissues (p > 0.05; Figure 1A).